Logo image of SXTC

CHINA SXT PHARMACEUTICALS IN (SXTC) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:SXTC - VGG2161P1577 - Common Stock

1.56 USD
-0.05 (-3.11%)
Last: 12/22/2025, 1:32:58 PM

SXTC Key Statistics, Chart & Performance

Key Statistics
Market Cap181.01M
Revenue(TTM)1.74M
Net Income(TTM)-3.30M
Shares116.03M
Float75.04M
52 Week High7.84
52 Week Low0.95
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-3.01
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO2019-01-04
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


SXTC short term performance overview.The bars show the price performance of SXTC in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10

SXTC long term performance overview.The bars show the price performance of SXTC in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of SXTC is 1.56 USD. In the past month the price increased by 19.7%. In the past year, price decreased by -37.11%.

CHINA SXT PHARMACEUTICALS IN / SXTC Daily stock chart

SXTC Latest News, Press Relases and Analysis

SXTC Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 48.57 1.01T
JNJ JOHNSON & JOHNSON 19.99 499.85B
MRK MERCK & CO. INC. 11.8 258.06B
PFE PFIZER INC 7.88 143.39B
BMY BRISTOL-MYERS SQUIBB CO 8.32 111.07B
ZTS ZOETIS INC 19.47 54.39B
RPRX ROYALTY PHARMA PLC- CL A 9.4 22.30B
VTRS VIATRIS INC 5.13 13.76B
ELAN ELANCO ANIMAL HEALTH INC 23.27 11.10B
CORT CORCEPT THERAPEUTICS INC 96.02 8.89B
AXSM AXSOME THERAPEUTICS INC N/A 7.77B
BLTE BELITE BIO INC - ADR N/A 5.43B

About SXTC

Company Profile

SXTC logo image China Sxt Pharmaceuticals, Inc. operates as a holding company, which engages in the research, development, manufacture, marketing, and sales of traditional Chinese medicine pieces (TCMP). The company is headquartered in Taizhou, Jiangsu and currently employs 75 full-time employees. The company went IPO on 2019-01-04. The firm sells different types of TCMP products, including Advanced TCMP and Regular TCMP. Advanced TCMP comprises of Directly-Oral-TCMP and After-Soaking-Oral TCMP. Regular TCMP is mainly for hospitals and drug stores for the treatment of various diseases or serving as dietary supplements. The firm sells its products under the brand Suxuantang.

Company Info

CHINA SXT PHARMACEUTICALS IN

178 Taidong Road North

Taizhou JIANGSU 225300 CN

CEO: Feng Zhou

Employees: 75

SXTC Company Website

SXTC Investor Relations

Phone: 8652386298290

CHINA SXT PHARMACEUTICALS IN / SXTC FAQ

What does CHINA SXT PHARMACEUTICALS IN do?

China Sxt Pharmaceuticals, Inc. operates as a holding company, which engages in the research, development, manufacture, marketing, and sales of traditional Chinese medicine pieces (TCMP). The company is headquartered in Taizhou, Jiangsu and currently employs 75 full-time employees. The company went IPO on 2019-01-04. The firm sells different types of TCMP products, including Advanced TCMP and Regular TCMP. Advanced TCMP comprises of Directly-Oral-TCMP and After-Soaking-Oral TCMP. Regular TCMP is mainly for hospitals and drug stores for the treatment of various diseases or serving as dietary supplements. The firm sells its products under the brand Suxuantang.


Can you provide the latest stock price for CHINA SXT PHARMACEUTICALS IN?

The current stock price of SXTC is 1.56 USD. The price decreased by -3.11% in the last trading session.


Does CHINA SXT PHARMACEUTICALS IN pay dividends?

SXTC does not pay a dividend.


How is the ChartMill rating for CHINA SXT PHARMACEUTICALS IN?

SXTC has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Where is CHINA SXT PHARMACEUTICALS IN (SXTC) stock traded?

SXTC stock is listed on the Nasdaq exchange.


Can you provide the ownership details for SXTC stock?

You can find the ownership structure of CHINA SXT PHARMACEUTICALS IN (SXTC) on the Ownership tab.


SXTC Technical Analysis

ChartMill assigns a technical rating of 5 / 10 to SXTC. When comparing the yearly performance of all stocks, SXTC is a bad performer in the overall market: 88.18% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

SXTC Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to SXTC. The financial health of SXTC is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SXTC Financial Highlights

Over the last trailing twelve months SXTC reported a non-GAAP Earnings per Share(EPS) of -3.01. The EPS increased by 97.31% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -15.25%
ROE -21.4%
Debt/Equity 0.05
Chartmill High Growth Momentum
EPS Q2Q%-102.39%
Sales Q2Q%-7.84%
EPS 1Y (TTM)97.31%
Revenue 1Y (TTM)-9.73%

SXTC Forecast & Estimates


Analysts
Analysts0
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

SXTC Ownership

Ownership
Inst Owners0.25%
Ins Owners35.32%
Short Float %0.23%
Short Ratio1.12